This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Alexandria Real Estate Equities, Inc. To Ring Today's Closing Bell At New York Stock Exchange

Stocks in this article: ARE

NEW YORK, July 13, 2012 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the largest and leading owner, operator and developer of high-quality, sustainable real estate for the broad and diverse life science industry in key innovation clusters, announced that it will ring The Closing Bell at the NYSE today, Friday, July 13, 2012, to commemorate the Company's 15th anniversary as a publicly traded company.

The board of directors and members of Alexandria's executive management team will join Joel S. Marcus, Chairman, Chief Executive Officer and Founder of Alexandria, as he rings The Closing Bell at 4:00 p.m. EDT. A live webcast of the ceremony will be available beginning at 3:59 p.m. EDT at the NYSE's website, www.nyse.com. Photos and video of the NYSE Bell Ringing Ceremony will also be available, courtesy of the NYSE, on Facebook (NYSE Euronext-Official Site), Twitter (@NYSE_Euronext) and YouTube (nysetv1).

"We are honored that the NYSE has invited us to ring The Closing Bell as we celebrate 15 years as a publicly traded company," said Mr. Marcus. "This milestone achievement and Alexandria's record of long-term success are a result of our world-class employees, investors, life science network and client tenant partners who continue to position Alexandria as the leader in life science real estate."

Alexandria was founded in 1994 by Mr. Marcus and Dr. Jerry Sudarsky as the first real estate investment trust (REIT) to identify and specialize in the life science niche. From its origination as a garage start-up, the Company went public on the NYSE in May 1997. Since that date, the Company has generated a total return of approximately 570% through June 30, 2012, assuming the reinvestment of all dividends. In July 2011, Alexandria received investment-grade ratings, which reflect the Company's continued leadership of the life science real estate niche; the strength of its credit profile and business; the size and quality of its real estate holdings; its consistent operating and leasing performance; its unmatched life science and real estate experience and expertise; the importance of its key cluster locations; stable net operating income from high-credit client tenants; and its continued focus on maintaining a conservative balance sheet. This is also a testament to the Company's high-credit life science industry client tenant base, a defining and unique characteristic of Alexandria. As of June 30, 2012, investment-grade client tenants represented approximately 47% of Alexandria's annualized base rent and included Novartis AG, Eli Lilly and Company, Roche Holding Ltd, Pfizer Inc., Biogen Idec Inc., The Regents of the University of California, and Bristol-Myers Squibb Company.

About Alexandria Real Estate Equities, Inc.Alexandria Real Estate Equities, Inc. (NYSE: ARE) is the largest and leading investment-grade real estate investment trust focused principally on owning, operating, and developing high-quality, sustainable real estate for the broad and diverse life science industry.  Founded in 1994, Alexandria has the first-mover advantage in every core life science cluster location, including Greater Boston, San Francisco Bay, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park. Alexandria's high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, U.S. government research agencies, medical device companies, clean technology companies, venture capitalists, and life science product and service companies. As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity and innovation through its best-in-class laboratory and office space, collaborative locations proximate to leading research institutions, unparalleled life science real estate expertise and services, and longstanding and expansive network in the life science community. For additional information on Alexandria Real Estate Equities, Inc., please visit www.are.com.

This press release contains forward-looking statements within the meaning of the federal securities laws. Actual results may differ materially from those projected in the forward-looking statements. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained in our Annual Report on Form 10-K and our other periodic reports filed with the Securities and Exchange Commission.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs